Intellectual Property India Publishes Patent Application for 'Parp7 Inhibitors' Filed by Gilead Sciences, Inc.

MUMBAI, India, March 14 -- Intellectual Property India has published a patent application (202617016791 A) filed by Gilead Sciences, Inc., Foster City, U.S.A., on Feb. 16, for 'parp7 inhibitors.'

Inventor(s) include Chang, Jonah, J.; Chandrasekhar, Jayaraman; Currie, Kevin, S.; Holmbo, Stephen, D.; Jacobsen, Jesse, M.; Kukla, David, L; Lee, Seung, H.; Moazami, Yasamin; Patel, Leena, B.; Paul, Thomas, J.; Perreault, Stephane; Salvo, Patrick, J.; Treiberg, Jennifer, A.; and Weaver, Heath, A.

The application for the patent was published on March 13, under issue no. 11/2026.

According to the abstract released by the Intellectual Property India: "Provided herein is a compound of Formula (I): or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or deuterated analog thereof, a pharmaceutical composition comprising a compound of the present disclosure, together with a pharmaceutically acceptable excipient thereof, and a method of treating cancer with the same."

The patent application was internationally filed on July 25, 2024, under International application No.PCT/US2024/039549.

Disclaimer: Curated by HT Syndication.